BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15585550)

  • 1. Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease.
    Suri D; Weiss RE
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1340-6. PubMed ID: 15585550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro.
    Auernhammer CJ; Stalla GK; Lange M; Pfeiffer A; Müller OA
    J Clin Endocrinol Metab; 1992 Aug; 75(2):552-7. PubMed ID: 1322429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
    Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
    J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
    Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
    J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic Cushing's syndrome combined with cortisol suppressible, dexamethasone non-suppressible ACTH secretion: a new variant of Cushing's syndrome.
    Schweikert HU; Fehm HL; Fahlbusch R; Martin R; Kolloch R; Higuchi M; Krück F
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):289-95. PubMed ID: 3000118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRH in Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of pituitary and adrenocortical suppression after long-term administration of anti-inflammatory doses of prednisone in dogs.
    Moore GE; Hoenig M
    Am J Vet Res; 1992 May; 53(5):716-20. PubMed ID: 1326243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
    Schteingart DE; McKenzie AK
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1195-8. PubMed ID: 6252234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the twenty-four hour secretion patterns of adrenocorticotropin and cortisol in normal women and patients with Cushing's disease.
    Liu JH; Kazer RR; Rasmussen DD
    J Clin Endocrinol Metab; 1987 May; 64(5):1027-35. PubMed ID: 3031116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report: Complete restoration of the HPA axis function in Cushing's disease with drug treatment.
    Nguyen JT; Ferrière A; Tabarin A
    Front Endocrinol (Lausanne); 2024; 15():1337741. PubMed ID: 38390203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian cortisol secretory rhythms in Cushing's disease.
    Boyar RM; Witkin M; Carruth A; Ramsey J
    J Clin Endocrinol Metab; 1979 May; 48(5):760-5. PubMed ID: 219007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Treatment of Cushing's Disease.
    Pivonello R; De Leo M; Cozzolino A; Colao A
    Endocr Rev; 2015 Aug; 36(4):385-486. PubMed ID: 26067718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin II infusion on the early morning surge of ACTH and o-CRH-provoked ACTH secretion in normal man.
    Haller H; Hensen J; Bähr V; Oelkers W
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):150-6. PubMed ID: 3017033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary-adrenocortical function in chronic renal failure: blunted suppression and early escape of plasma cortisol levels after intravenous dexamethasone.
    Rosman PM; Farag A; Peckham R; Benn R; Tito J; Bacci V; Wallace EZ
    J Clin Endocrinol Metab; 1982 Mar; 54(3):528-33. PubMed ID: 7056840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the opiate agonist loperamide on pituitary-adrenal function in patients with suspected hypercortisolism.
    Ambrosi B; Bochicchio D; Ferrario R; Colombo P; Faglia G
    J Endocrinol Invest; 1989 Jan; 12(1):31-5. PubMed ID: 2545766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.